Literature DB >> 4687372

Tyrosinosis: a new variant.

W A Zaleski, A Hill.   

Abstract

ABNORMALITIES OF TYROSINE METABOLISM ARE DISCUSSED UNDER FOUR HEADINGS: (1) accumulation of tyrosine and its metabolites secondary to severe liver damage, vitamin C deficiency, etc.; (2) transient neonatal tyrosinemia; (3) hereditary tyrosinosis with hepatorenal dysfunction where elevation of tyrosine and methionine levels in the plasma may be a secondary manifestation of an unknown disease process; and (4) "essential tyrosinemia" or tyrosinosis without hepatorenal dysfunction which may represent a kkrimary fault in the metabolism of tyrosine.A new case of tyrosinosis without hepatorenal dysfunction in a 13-year-old mentally retarded girl is reported. Clinical findings, laboratory investigations and results of dietary management and normalization of the plasma tyrosine level and of urinary metabolites are presented and compared with the features of three similar cases in the liteature. It is suggested that these cases represent "essential tyrosinemia" where there is a primary genetic defect in tyrosine metabolism.

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4687372      PMCID: PMC1941207     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN: 0008-4409            Impact factor:   8.262


  22 in total

1.  A new error of tyrosine metabolism: tyrosinosis. The intermediary metabolism of tyrosine and phenylalanine.

Authors:  G Medes
Journal:  Biochem J       Date:  1932       Impact factor: 3.857

2.  Soluble and mitochondrial forms of tyrosine aminotransferase. Relationship to human tyrosinemia.

Authors:  J H Fellman; P J Vanbellinghen; R T Jones; R D Koler
Journal:  Biochemistry       Date:  1969-02       Impact factor: 3.162

3.  Unusual radiological changes in tyrosinosis.

Authors:  W A Zeleski; C S Houston; A Hill
Journal:  Lancet       Date:  1972-07-01       Impact factor: 79.321

4.  Diagnosis and treatment of tyrosinosis.

Authors:  A Fairney; D Francis; R S Ersser; J W Seakins; D Cottom
Journal:  Arch Dis Child       Date:  1968-10       Impact factor: 3.791

5.  Dietary treatment of tyrosinosis.

Authors:  A Hill; P M Nordin; W A Zaleski
Journal:  J Am Diet Assoc       Date:  1970-04

6.  Recovery after dietary treatment of an infant with features of tyrosinosis.

Authors:  J T Harries; J W Seakins; R S Ersser; J K Lloyd
Journal:  Arch Dis Child       Date:  1969-04       Impact factor: 3.791

7.  Transient tyrosinemia in full-term infants.

Authors:  H L Levy; V E Shih; P M Madigan; R A MacCready
Journal:  JAMA       Date:  1969-07-14       Impact factor: 56.272

8.  Effects of reducing the phenylalanine-tyrosine intake of patients with advanced malignant melanoma.

Authors:  H B Demopoulos
Journal:  Cancer       Date:  1966-05       Impact factor: 6.860

9.  Hereditary tyrosinemia and tyrosyluria: clinical report of four patients.

Authors:  C R Scriver; M Silverberg; C L Clow
Journal:  Can Med Assoc J       Date:  1967-10-28       Impact factor: 8.262

10.  Tyrosinaemia and tyrosyluria in infancy.

Authors:  P W Wong; A M Lambert; G M Komrower
Journal:  Dev Med Child Neurol       Date:  1967-10       Impact factor: 5.449

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.